BROOKS Stock Overview
Manufactures and sells pharmaceuticals in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Brooks Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹141.48 |
| 52 Week High | ₹185.70 |
| 52 Week Low | ₹73.25 |
| Beta | 1.54 |
| 11 Month Change | -2.67% |
| 3 Month Change | 9.15% |
| 1 Year Change | 10.02% |
| 33 Year Change | 30.94% |
| 5 Year Change | 354.19% |
| Change since IPO | 2,076.62% |
Recent News & Updates
Recent updates
Would Brooks Laboratories (NSE:BROOKS) Be Better Off With Less Debt?
Sep 28
Does Brooks Laboratories (NSE:BROOKS) Have A Healthy Balance Sheet?
Jun 10Estimating The Intrinsic Value Of Brooks Laboratories Limited (NSE:BROOKS)
Feb 22Is Brooks Laboratories (NSE:BROOKS) Using Too Much Debt?
Dec 08Is Brooks Laboratories (NSE:BROOKS) A Risky Investment?
Jul 07Here's Why Brooks Laboratories (NSE:BROOKS) Can Afford Some Debt
Jan 05Brooks Laboratories (NSE:BROOKS) Is Making Moderate Use Of Debt
Sep 22
Shareholder Returns
| BROOKS | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | 5.8% | -0.3% | -1.8% |
| 1Y | 10.0% | 47.9% | 27.2% |
Return vs Industry: BROOKS underperformed the Indian Life Sciences industry which returned 47.9% over the past year.
Return vs Market: BROOKS underperformed the Indian Market which returned 27.2% over the past year.
Price Volatility
| BROOKS volatility | |
|---|---|
| BROOKS Average Weekly Movement | 7.1% |
| Life Sciences Industry Average Movement | 6.5% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: BROOKS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: BROOKS's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 293 | n/a | www.brookslabs.net |
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. The company offers liquid and dry powder injection, carbapenem dry powder injectables, tablets, oral suspension, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
Brooks Laboratories Limited Fundamentals Summary
| BROOKS fundamental statistics | |
|---|---|
| Market cap | ₹3.71b |
| Earnings (TTM) | -₹198.61m |
| Revenue (TTM) | ₹781.93m |
4.7x
P/S Ratio-18.7x
P/E RatioIs BROOKS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BROOKS income statement (TTM) | |
|---|---|
| Revenue | ₹781.93m |
| Cost of Revenue | ₹540.35m |
| Gross Profit | ₹241.58m |
| Other Expenses | ₹440.20m |
| Earnings | -₹198.61m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.57 |
| Gross Margin | 30.90% |
| Net Profit Margin | -25.40% |
| Debt/Equity Ratio | 12.1% |
How did BROOKS perform over the long term?
See historical performance and comparison